Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids
- 25 July 2005
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 300 (1-2) , 125-130
- https://doi.org/10.1016/j.ijpharm.2005.06.007
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugatesAdvanced Drug Delivery Reviews, 2003
- Polysialylated insulin: synthesis, characterization and biological activity in vivoBiochimica et Biophysica Acta (BBA) - General Subjects, 2003
- Effect of pegylation on pharmaceuticalsNature Reviews Drug Discovery, 2003
- Pharmaceutical biotechnology products approved within the European UnionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2003
- Polysialic acids: potential in drug deliveryPublished by Wiley ,2001
- The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokineticsInternational Journal of Pharmaceutics, 2001
- Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis CBioconjugate Chemistry, 2001
- Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeuticsCellular and Molecular Life Sciences, 2000
- Long-acting Growth Hormones Produced by Conjugation with Polyethylene GlycolJournal of Biological Chemistry, 1996
- Synthesis, characterization and properties of sialylated catalaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996